Tech Company Financing Transactions
Immuneering Funding Round
Cormorant Asset Management, BlackRock and Lyfe Capital joined a $62 million Series B funding round for Immuneering. This venture round was announced by the company on 1/6/2021.
Transaction Overview
Cormorant Asset Management (Lead Investor) (Andrew Phillips)
Company Information
Cambridge, MA 02142
USA
Management Team
Browse more venture capital transactions:
Prev: 1/6/2021: Botanical Solutions venture capital transaction
Next: 1/6/2021: Aro Biotherapeutics venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records on this site come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs